A2 Bio
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
30301 Agoura Rd Unit 210, Agoura Hills, ...Phone Number
(805) 491-1988Website
www.a2bio.comRevenue
$35.1 MillionIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
3
1
1
1
2
About A2 Bio
A2 Biotherapeutics is a fully integrated discovery, development, and manufacturing organization that focuses on biotechnology and cell therapy with an aim to beat cancer via tumor-specific targeting. The company was founded in 2018 and is headquartered in Agoura Hills, California.Explore more
A2 Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is A2 Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on A2 Bio recently announced quarterly report
Funding: Get notified immidiatlly once A2 Bio has new funding data
Congratulate Masked Content for being promoted to Masked Content at A2 Bio
Click to see if A2 Bio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if A2 Bio is spiking on competitors!
Check if A2 Bio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when A2 Bio launches new products
A2 Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined A2 Bio as Masked Content
Find 2 more new buyers
Compare Similar Companies to A2 Bio
Compare insights from companies similar to A2 Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
A2 Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
A2 Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about A2 Bio.
A2 Bio financials insights
Gather financial insights about A2 Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$57M
2020
Series B
$71.5M
2022
Other Financing Round
$62M
2025
Series C
$80M
A2 Bio Tech Stack
A closer look at the technologies used by A2 Bio
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Medical Research, Consumer Technology
A2 Bio News & Media
ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.
ST. PAUL, Minn., May 6, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf, Bio-Techne Corporation and CellReady, today announced that A2 Biotherapeutics, Inc. ("A2") has been awarded a $300,000 G-Rex® Grant. A2's G-Rex® Grant will enable expeditious process development...A2 Bio closes $80M Series C capital raise | Pacific Coast Business Times
James Robinson, CEO of A2 Biotherapeutics. (courtesy photo) Established in 2018, Agoura Hills-based A2 Biotherapeutics is developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells. The clinical-stage cell therapy company on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a syndicate of investors thatA2 Biotherapeutics Closes $80 Million Series C Financing to Advance Clinical Development of Its Precision Cell Therapies Using Its Proprietary Tmod™ Technology Platform
AGOURA HILLS, Calif.--(BUSINESS WIRE)--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells, today announced the closing of its $80 million Series C financing round, supported by a syndicate of investors that includes The Column Group and Samsara BioCapital. Proceeds will fund the company’s three clinical development programs and advancement of its pipeline of CAR-A2 Bio Highlights Progress of Tmod™ CAR T-Cell Clinical Programs During 2024 Annual Meeting of the Society for Immunotherapy of Cancer
HOUSTON--(BUSINESS WIRE)-- #ColorectalCancer--A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding A2 Bio
Sign Up For FreeTo access detailed company insights
A2 Biotherapeutics is a fully integrated discovery, development, and manufacturing organization that focuses on biotechnology and cell therapy with an aim to beat cancer via tumor-specific targeting. The company was founded in 2018 and is headquartered in Agoura Hills, California.... Read More
